Literature DB >> 7510402

An idiotope--anti-idiotope complex and the structural basis of molecular mimicking.

R J Poljak1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7510402      PMCID: PMC43209          DOI: 10.1073/pnas.91.5.1599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  [A new allotype form of rabbit serum gamma-globulins, apparently associated with antibody function and specificity].

Authors:  J OUDIN; M MICHEL
Journal:  C R Hebd Seances Acad Sci       Date:  1963-07-17

Review 2.  Idiotypic mimicry of biological receptors.

Authors:  G N Gaulton; M I Greene
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Receptor anti-idiotypes. Mimics--or gimmicks?

Authors:  D I Meyer
Journal:  Nature       Date:  1990-10-04       Impact factor: 49.962

4.  Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution.

Authors:  A G Amit; R A Mariuzza; S E Phillips; R J Poljak
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

5.  Immune response to a molecularly defined internal image idiotope.

Authors:  W V Williams; S D London; D B Weiner; S Wadsworth; J A Berzofsky; F Robey; D H Rubin; M I Greene
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

6.  Idiotypic networks and their possible exploitation for manipulation of the immune response.

Authors:  I M Roitt; A Cooke; D K Male; F C Hay; G Guarnotta; P M Lydyard; L P de Carvalho; Y Thanavala; J Ivanyi
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

7.  Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production.

Authors:  A Nisonoff; E Lamoyi
Journal:  Clin Immunol Immunopathol       Date:  1981-12

Review 8.  Induction of immune responses with anti-idiotypic antibodies: implications for the induction of protective immunity.

Authors:  D L Sacks; G H Kelsoe; D H Sachs
Journal:  Springer Semin Immunopathol       Date:  1983

9.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

10.  Studies of idiotypic antibodies. Production and characterization of autoantiidiotypic antisera.

Authors:  L S Rodkey
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  6 in total

1.  Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.

Authors:  Dakshnamurthy Selvakumar; Masahiko Miyamoto; Yasuhiro Furuichi; Tadazumi Komiyama
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-α receptor 1.

Authors:  M C Holland; J U Wurthner; P J Morley; M A Birchler; J Lambert; M Albayaty; A P Serone; R Wilson; Y Chen; R M Forrest; J C Cordy; D A Lipson; A I Bayliffe
Journal:  J Clin Immunol       Date:  2013-07-06       Impact factor: 8.317

3.  Characterization of anti-anti-idiotypic antibodies that bind antigen and an anti-idiotype.

Authors:  F A Goldbaum; C A Velikovsky; W Dall'Acqua; C A Fossati; B A Fields; B C Braden; R J Poljak; R A Mariuzza
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.

Authors:  L Polonelli; N Séguy; S Conti; M Gerloni; D Bertolotti; C Cantelli; W Magliani; J C Cailliez
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

5.  Anti-idiotypic antibodies: a new approach in prion research.

Authors:  Anja Colja Venturini; Maja Bresjanac; Tanja Vranac; Simon Koren; Mojca Narat; Mara Popović; Vladka Curin Serbec
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

6.  The promise of the anti-idiotype concept.

Authors:  Thomas Kieber-Emmons; Bejatohlah Monzavi-Karbassi; Anastas Pashov; Somdutta Saha; Ramachandran Murali; Heinz Kohler
Journal:  Front Oncol       Date:  2012-12-19       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.